Stereotaxis (STXS) Stock Price Target 2026

The average analyst price target for Stereotaxis is $3.75. Of 6 analysts, 6 rate it Buy. Targets range from $3 to $5. The latest change came on Aug 27, 2026, when Citizens lowered its price target on Stereotaxis from $4 to $3 and kept a Market Outperform rating.

The Average Analyst Price Target for Stereotaxis is $3.75.

Price Target Range — 4 Quarters

Analyst Consensus — 6 Analysts

1S.Buy

5Buy

Consensus RatingBuy# Analysts6Avg. Consensus PT$3.75

Rating Trend — Last 9 Months

Latest Upgrades and Downgrades for Stereotaxis Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 27, 2026	Citizens	Daniel Stauder	PT Cut	Market Outperform	$4→$3
Aug 12, 2026	TD Cowen	Joshua Jennings	PT Cut	Buy	$5→$3
May 13, 2026	Piper Sandler	Adam Maeder	PT Cut	Overweight	$4→$4
Dec 16, 2025	Citizens	Daniel Stauder	Initiate	Market Outperform	$4
Nov 12, 2025	Roth Capital	Kyle Bauser	Maintained	Buy	$4
Nov 5, 2025	Roth Capital	Kyle Bauser	Reinstates	Buy	$4
Mar 5, 2024	Lake Street	Frank Takkinen	PT Raise	Buy	$3→$4
Mar 5, 2024	Roth MKM	Jason Wittes	Maintained	Buy	$5
Jan 10, 2024	Roth MKM	Jason Wittes	Initiate	Buy	$5

Analyst Ratings News

PRO
Citizens Maintains Market Outperform on Stereotaxis, Lowers Price Target to $3

Citizens analyst Daniel Stauder maintains Stereotaxis (AMEX:STXS) with a Market Outperform and lowers the price target from $4 to $3.

Benzinga Newsdesk

PRO
TD Cowen Maintains Buy on Stereotaxis, Lowers Price Target to $3

TD Cowen analyst Joshua Jennings maintains Stereotaxis (AMEX:STXS) with a Buy and lowers the price target from $5 to $3.

Benzinga Newsdesk

PRO
Piper Sandler Reiterates Overweight on Stereotaxis, Lowers Price Target to $3.5

Piper Sandler analyst Adam Maeder reiterates Stereotaxis (AMEX:STXS) with a Overweight and lowers the price target from $4 to $3.5.

Benzinga Newsdesk

This MYR Group Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Tuesday

Avi Kapoor

PRO
Citizens Initiates Coverage On Stereotaxis with Market Outperform Rating, Announces Price Target of $4

Citizens analyst Daniel Stauder initiates coverage on Stereotaxis (AMEX:STXS) with a Market Outperform rating and announces Price Target of $4.

Benzinga Newsdesk

PRO
Roth Capital Reiterates Buy on Stereotaxis, Maintains $4 Price Target

Roth Capital analyst Kyle Bauser reiterates Stereotaxis (AMEX:STXS) with a Buy and maintains $4 price target.

Benzinga Newsdesk

Stereotaxis Inc

Stereotaxis (STXS) Stock Price Target 2026

The Average Analyst Price Target for Stereotaxis is $3.75.

Latest Upgrades and Downgrades for Stereotaxis Stock

Analyst Ratings News

PRO
Citizens Maintains Market Outperform on Stereotaxis, Lowers Price Target to $3

PRO
TD Cowen Maintains Buy on Stereotaxis, Lowers Price Target to $3

PRO
Piper Sandler Reiterates Overweight on Stereotaxis, Lowers Price Target to $3.5

This MYR Group Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Tuesday

PRO
Citizens Initiates Coverage On Stereotaxis with Market Outperform Rating, Announces Price Target of $4

PRO
Roth Capital Reiterates Buy on Stereotaxis, Maintains $4 Price Target

People Also Watch

People Also Watch

Stereotaxis Inc

Stereotaxis (STXS) Stock Price Target 2026

The Average Analyst Price Target for Stereotaxis is $3.75.

Latest Upgrades and Downgrades for Stereotaxis Stock

Analyst Ratings News

PROCitizens Maintains Market Outperform on Stereotaxis, Lowers Price Target to $3

PROTD Cowen Maintains Buy on Stereotaxis, Lowers Price Target to $3

PROPiper Sandler Reiterates Overweight on Stereotaxis, Lowers Price Target to $3.5

This MYR Group Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Tuesday

PROCitizens Initiates Coverage On Stereotaxis with Market Outperform Rating, Announces Price Target of $4

PRORoth Capital Reiterates Buy on Stereotaxis, Maintains $4 Price Target

People Also Watch

People Also Watch

PRO
Citizens Maintains Market Outperform on Stereotaxis, Lowers Price Target to $3

PRO
TD Cowen Maintains Buy on Stereotaxis, Lowers Price Target to $3

PRO
Piper Sandler Reiterates Overweight on Stereotaxis, Lowers Price Target to $3.5

PRO
Citizens Initiates Coverage On Stereotaxis with Market Outperform Rating, Announces Price Target of $4

PRO
Roth Capital Reiterates Buy on Stereotaxis, Maintains $4 Price Target